Showing results (51-60 of 145) with videos related to

Sort By:
Pageof 15
Diagnostic Pathology|October 23, 2019
Treg/Th17 imbalance and its clinical significance in patients with hepatitis B-associated liver cirrhosisYong-Ting Lan, Zhen-Li Wang, Peng Tian, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|March 6, 2023
Hypomethylation of glycine dehydrogenase promoter in peripheral blood mononuclear cells is a new diagnostic marker of hepatitis B virus-associated hepatocellular carcinomaLi-Li Miao, Jing-Wen Wang, Hui-Hui Liu, et al.
Clinical and Experimental Medicine|July 6, 2017
Aberrant GSTP1 promoter methylation predicts poor prognosis of acute-on-chronic hepatitis B pre-liver failureChen-Yang Qiao, Feng Li, Yue Teng, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|June 4, 2013
[Cellular toxicity and anti-tumor efficacy of iRGD modified doxorubixin loaded sterically stabilized liposomes]Bo Zhao, Yu-Chen Fan, Xue-Qing Wang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 8, 2026
Exposure to Environmental Pollutants and Nonalcoholic Fatty Liver Disease: A Cross-Sectional StudyYing Zhang, Han-Xu Zhu, Feng Zhang, et al.
Journal of Clinical Immunology|September 17, 2009
Implication of Th17 and Th1 cells in patients with chronic active hepatitis BJian Ge, Kai Wang, Qing-Hua Meng, et al.
Pathology, Research and Practice|August 28, 2020
RIPK3 mRNA level acts as a diagnostic biomarker in hepatitis B virus-associated hepatocellular carcinomaLi-Yan Han, Jie-Ru Yang, Ze-Hua Zhao, et al.
Journal of Clinical and Translational Hepatology|May 9, 2022
Risk Factors of Chronic Kidney Disease in Chronic Hepatitis B: A Hospital-based Case-control Study from ChinaYunqi Liu, Ximei Wang, Fuping Xu, et al.
Pageof 15